Kenvue Inc KVUE

Morningstar Rating
$17.20 −0.02 (0.12%)
View Full Chart

Company Report

Kenvue To Be Acquired by Kimberly-Clark To Create a Personal Care Giant

Kenvue is the world’s largest pure-play consumer health company by revenue, generating over $15 billion in annual sales. The former consumer segment of Johnson & Johnson spun off and went public in May 2023. We expect Kenvue to focus on its 15 priority brands (including Tylenol, Nicorette, Listerine, and Zyrtec) to drive future growth. We forecast the firm to spend roughly 3% of sales on research and development, on par with some of its wide-moat competitors, to launch innovative products.

Price vs Fair Value

KVUE is trading at a LOCK|@c%&yv premium.
Price
$17.22
Fair Value
?x
Uncertainty
LOCK|Zmx
1-Star Price
LOCK|.V?
5-Star Price
LOCK|.<
Economic Moat
LOCK|NnL
Capital Allocation
LOCK|%DWB?!

Bulls Say, Bears Say

Bulls

With autonomy from its former parent, Kenvue can allocate resources to best fit its needs and expand the business.

Bears

Negative press on Tylenol, Kenvue's biggest product by revenue, from the White House could adversely affect demand and hurt future earnings potential.

News

Articles & Videos

Trading Information

Previous Close Price
$17.22
Day Range
$17.16–17.38
52-Week Range
$14.02–20.13
Bid/Ask
$17.18 / $17.25
Shares Outstanding
1.92B
Market Cap
$33.04B
Volume/Avg
14M / 22M

Key Statistics

Price/Earnings (Normalized)
14.59
Price/Sales
2.15
Dividend Yield (Trailing)
4.85%
Dividend Yield (Forward)
4.88%
Dividend Payment Schedule
Feb, May, Aug, Oct, Nov
Total Yield
5.06%

Company Profile

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Sector
Consumer Defensive
Industry
Household & Personal Products
Stock Style Box
Mid Value
Total Number of Employees
22,000

Competitors

Valuation

Metric
KVUE
KMB
PG
Price/Earnings (Normalized)
14.5915.0221.21
Price/Book Value
3.1317.936.20
Price/Sales
2.151.904.01
Price/Cash Flow
13.9710.6018.17
Price/Earnings
KVUE
KMB
PG

Financial Strength

Metric
KVUE
KMB
PG
Quick Ratio
0.690.400.41
Current Ratio
1.010.910.68
Interest Coverage
6.1210.4023.74
Quick Ratio
KVUE
KMB
PG

Profitability

Metric
KVUE
KMB
PG
Return on Assets (Normalized)
7.32%10.43%13.14%
Return on Equity (Normalized)
18.54%117.92%31.34%
Return on Invested Capital (Normalized)
11.61%22.28%19.01%
Return on Assets
KVUE
KMB
PG

Household & Personal Products Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Procter & Gamble Co
PG
LOCK|Zb@?D<$?LOCK|GPg$334B
L'Oreal SA
LRLCF
—LOCK|%Z>$224B
Unilever PLC ADR
UL
LOCK|C%P%rpLOCK|$^$128B
Colgate-Palmolive Co
CL
LOCK|%^hws?tLOCK|&$$67B
Reckitt Benckiser Group PLC ADR
RBGLY
LOCK|GnDbxJLOCK|$&?$41B
The Estee Lauder Companies Inc Class A
EL
LOCK|%ftG&KLOCK|@PQ$33B
Kimberly-Clark Corp
KMB
LOCK|G&T>&TLOCK|N?G#$31B
Church & Dwight Co Inc
CHD
LOCK|b>$KMfLOCK|rg$22B
Clorox Co
CLX
LOCK|?#ST$JcJLOCK|h@$10B

Sponsor Center